Key Dates

Related Announcements

RFA-HL-22-012 - Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform applicants effective immediately of changes to the Advisory Council Review, Application Due Date, and Expiration Date for RFA-HL-22-012, "Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)". Specifically, this Notice changes only the following:

Currently Reads:

Part 1. Overview Information

Key Dates

Application Due Date(s): August 9, 2021, February 23, 2022, August 9, 2022, February 23, 2023, August 9, 2023, February 23, 2024
Advisory Council Review: January 2022, October 2022, January 2023, October 2023, January 2024, October 2024
Expiration Date: February 24, 2024

Modified to Read (changes shown in bold italics and/or strikethrough):

Part 1. Overview Information

Key Dates

Application Due Date(s): August 9, 2021, February 23, 2022, August 9, 2022, February 23, 2023, August 9, 2023,February 23, 2024
Advisory Council Review: January 2022, October 2022, January 2023, October 2023, January 2024, October 2024
Expiration Date:August 10, 2023

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries regarding this Notice to:

Scientific/Research Contact(s)

Desirée L. Salazar, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-480-4177
Email: [email protected]

Li-Shin Huang, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0535
Email: [email protected]

Peer Review Contact(s)

Director, Office of Scientific Review
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0270
Email: [email protected]

Financial/Grants Management Contact(s)

Tracee Foster
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8030
Email: [email protected]